Intralymphatic immunization enhances DNA vaccination

AUTOR(ES)

Maloy, Kevin J.

FONTE

The National Academy of Sciences

RESUMO

Although DNA vaccines have been shown to elicit potent immune responses in animal models, initial clinical trials in humans have been disappointing, highlighting a need to optimize their immunogenicity. Naked DNA vaccines are usually administered either i.m. or intradermally. The current study shows that immunization with naked DNA by direct injection into a peripheral lymph node enhances immunogenicity by 100- to 1,000-fold, inducing strong and biologically relevant CD8+ cytotoxic T lymphocyte responses. Because injection directly into a lymph node is a rapid and easy procedure in humans, these results have important clinical implications for DNA vaccination.

Documentos Relacionados

• DNA Vaccination against Tuberculosis: Expression of a Ubiquitin-Conjugated Tuberculosis Protein Enhances Antimycobacterial Immunity
• National immunization program: vaccination, compliance and pharmacovigilance
• DNA Vaccination by Electroporation and Boosting with Recombinant Proteins Enhances the Efficacy of DNA Vaccines for Schistosomiasis Japonica ▿
• Papillary intralymphatic angioendothelioma: Dabska tumor,
• Factors Associated with Missed Vaccination during Mass Immunization Campaigns